The potential role of inflammation in cryptogenic stroke

Gąsiorek, 2018, Bielecka-Dabrowa A et al. Established and potential echocardiographic markers of embolism and their therapeutic implications in patients with ischemic stroke, Cardiol J Saver, 2016, Cryptogenic stroke, N Engl J Med, 15, 375 Tuttolomondo, 2011, Effects of clinical and laboratory variables and of pretreatment with cardiovascular drugs in acute ischaemic stroke: a retrospective chart review from the GIFA study, Int J Cardiol, 151, 318, 10.1016/j.ijcard.2010.06.005 Kim, 2010, Plasma biomarkers in the diagnosis of acute ischemic stroke, Ann Clin Lab Sci, 40, 336 Yanying, 2014, Potential serum biomarkers in the pathophysiological processes of stroke, Expert Rev Neurother, 14, 173, 10.1586/14737175.2014.875471 Di Raimondo, 2012, Effects of ACE-inhibitors and angiotensin receptor blockers on inflammation, Curr Pharm Des, 18, 4385, 10.2174/138161212802481282 Licata, 2006, Immunoinflammatory activation during the acute phase of lacunar and non-lacunar ischemic stroke: association with time of onset and diabetic state, Int J Immunopathol Pharmacol, 19, 639, 10.1177/039463200601900320 Hsu, 2014, Asymmetric dimethylarginine and long-term adverse cardiovascular events in patients with type 2 diabetes: relation with the glycemic control, Cardiovasc Diabetol, 13, 156, 10.1186/s12933-014-0156-1 Szegedi, 2017, Potential biological markers of atrial fibrillation: a chance to prevent cryptogenic stroke, Biomed Res Int, 2017, 8153024, 10.1155/2017/8153024 Strand, 2015, Shedding of syndecan 4 promotes immune cell recruitment and mitigates cardiac dysfunction after lipopolysaccharide challenge in mice, J Mol Cell Cardiol, 88, 133, 10.1016/j.yjmcc.2015.10.003 Solbu, 2018, Gender differences in the association of syndecan-4 with myocardial infarction: the population-based Tromsø Study, Atherosclerosis, 278, 166, 10.1016/j.atherosclerosis.2018.08.005 Opatrilova, 2018, Adipokines in neurovascular diseases, Biomed Pharmacother, 98, 424, 10.1016/j.biopha.2017.12.074 Jenna, 2018, Role of adiponectin in central nervous system disorders, Neural Plast Menon, 2018, Role of leptin in acute ischemic stroke, Journal, 9, 376 Lee, 2015, The N-terminal propeptide of type III procollagen in patients with acute coronary syndrome: a link between left ventricular end-diastolic pressure and cardiovascular events, PLoS One, 10, 10.1371/journal.pone.0114097 Agarwal, 2014, Fibrosis-related biomarkers and incident cardiovascular disease in older adults: the cardiovascular health study, Circ Arrhythm Electrophysiol, 7, 583, 10.1161/CIRCEP.114.001610 Youngyun, 2018, Association between obesity and carotid intima-media thickness in Korean office workers: the mediating effect of physical activity, Biomed Res Int Sobczak, 2010, Plasma methylarginines, non-conventional risk factors of coronary-artery disease among subjects exposed and non-exposed to tobacco smoke, Environ Med, 13, 65 Tuttolomondo, 2013, A. Neurological complications of anderson-fabry disease, Curr Pharm Des, 19, 6014, 10.2174/13816128113199990387 Tuttolomondo, 2013, Anderson- Fabry disease: a multiorgan disease, Curr Pharm Des, 19, 5974, 10.2174/13816128113199990352 Chao, 2013, Plasma asymmetric dimethylarginine and adverse events in patients with atrial fibrillation referred for coronary angiogram, PLoS One, 8, 10.1371/journal.pone.0071675 Böger, 2005, Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials, Vasc Med, 10, 19, 10.1191/1358863x05vm602oa Solovyeva, 2015, The clinical laboratory markers of atherosclerosis in patients with atherothrombotic stroke, Kliniceskaja Laboratornaja Diagnostika, 60, 12 Nishiyama, 2014, Asymmetric dimethylarginine is related to the predicted stroke risk in middle-aged Japanese men, J Neurol Sci, 338, 87, 10.1016/j.jns.2013.12.021 Lao, 2016, Effect of asymmetrical dimethylarginine for predicting pro-thrombotic risk in atrial fibrillation, Zhonghua Yi Xue Za Zhi, 96, 2059 Satoh, 2018, N-terminal pro-B-type natriuretic peptide is not a significant predictor of stroke incidence after 5 years – the Ohasama Study, Circ J, 82, 2055, 10.1253/circj.CJ-17-1227 Leong, 2008, Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg. Arteriosclerosis, Thrombosis and Vascular Biology, 28, 961, 10.1161/ATVBAHA.107.156596 Krzyzanowska, 2007, Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes, Diabetes Care, 30, 1834, 10.2337/dc07-0019 Wanby, 2006, Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population, Atherosclerosis, 185, 271, 10.1016/j.atherosclerosis.2005.06.033 Rueda-Clausen, 2012, Increased plasma levels of total homocysteine but not asymmetric dimethylarginine in Hispanic subjects with ischemic stroke FREC-VI sub-study, Eur J Neurol, 19, 417, 10.1111/j.1468-1331.2011.03534.x Chen, 2012, Asymmetric dimethyarginine as marker and mediator in ischemic stroke, Int J Mol Sci, 13, 15983, 10.3390/ijms131215983 Bai, 2018, Detection of cardioembolic stroke with B-type natriuretic peptide or N-terminal pro-BNP: a comparative diagnostic meta-analysis, Int J Neurosci, 128, 1100, 10.1080/00207454.2017.1408612 Llombart, 2015, B-type natriuretic peptides help in cardio embolic stroke diagnosis: pooled data meta-analysis, Stroke, 46, 1187, 10.1161/STROKEAHA.114.008311 Duris, 2018, The role of inflammatory response in stroke associated programmed cell death, Curr Neuropharmacol, 16, 1365, 10.2174/1570159X16666180222155833 Yang, 2014, Association of IL-6-174G & C and -572C & G polymorphisms with risk of young ischemic stroke patients, Gene, 539, 258, 10.1016/j.gene.2014.01.054 Madoka, 2017, Time dependent transition of the levels of protein-conjugated acrolein (PC-Acro), IL-6 and CRP in plasma during stroke, Neurological Science, 7, 18 Shin Na, 2011, Impaired transport function of the left atrium and left atrial appendage in cryptogenic stroke patients with atrial septal aneurysm and without patent foramen ovale, Eur J Echocardiogr, 12, 140, 10.1093/ejechocard/jeq164 Armstead, 2019, Release of IL-6 after stroke contributes to impaired cerebral autoregulation and hippocampal neuronal necrosis through NMDA receptor activation and upregulation of ET-1 and JNK, Transl Stroke Res, 10, 104, 10.1007/s12975-018-0617-z Acampa, 2018, Atrial cardiopathy and sympatho-vagal imbalance in cryptogenic stroke: pathogenic mechanisms and effects on electrocardiographic markers, Frontiers Neurol, 9, 469, 10.3389/fneur.2018.00469 Acampa, 2019, Inflammation and atrial electrical remodelling in patients with embolic strokes of undetermined source, Heart Lung Circul, 28, 917, 10.1016/j.hlc.2018.04.294 Acampa, 2018, Electrocardiographic predictors of silent atrial fibrillation in cryptogenic stroke, Heart Lung Circul Billinger, 2017, The relationship of pro-inflammatory markers to vascular endothelial function after acute stroke, Int J Neurosci, 127, 486, 10.1080/00207454.2016.1198344